DOI : 10.1055/s-00034925

Hämostaseologie

Issue S 01 · Volume 39 · February 2019 DOI: 10.1055/s-009-42463


63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research
Berlin, Germany, 27.02 – 02.03.2019

Science meets clinical practice

Abstracts (HTML) List of Authors
P03-1
Mondorf, W.; Eichler, H.; Fischer, R.; Holstein, K.; Klamroth, R.; Nimtz-Talaska, A.; Richter, H.; Severin, K.; Wermes, C.: Comparison of Electronic Documentation with Smart Medicationtm between 2014 and 2017
P03-2/SY12-1-AB
Mahn, R.; Schilling, K.; Klamroth, R.; Kentouche, K.; Aumann, V.; Fischer, L.; Holzhauer, S.; Sirb, H.; Scholz, U.; Trautmann, K.; Halm-Heinrich, I.; Krammer-Steiner, B.; Koscielny, J.; Kreibisch, U.; Pietrzak-Büttner, A.; Tregel, M.; Knöfler, R.; Pfrepper, C.; Kompetenznetzwerk Hämorrhagische Diathese Ost: Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)
P03-3/SY17-2-AB
Oldenburg, J.; Mahlangu, J.; Paz-Priel, I.; Negrier, C.; Niggli, M.; Mancuso, M.E.; Schmitt, C.; Jiménez-Yuste, V.; Kempton, C.; Dhalluin, C.; Callaghan, M.; Bujan, W.; Shima, M.; Adamkewicz, J.I.; Asikanius, E.; Levy, G.G.; Kruse-Jarres, R.: Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study
P03-4
Tiede, A.; Bidlingmaier, C.; Heller, C.; Langer, F.; Oldenburg, J.; Miesbach, W.; Scholz, U.; van den, J. Boom; Reichert, A.; Willemze, A.: Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)
P03-5
Goldmann, G.; Wallny, T.; Müllejans, P.; Daub, U.; Marquardt, N.: Haemophilia and Osteoporosis Management in Germany
P03-6
Holstein, K.; Witt, L.; Rolvien, T.; Schmidt, T.; Amling, M.; Barvencik, F.; Matysiak, A.; Langer, F.: Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study
P03-7
von Mackensen, S.; Douma, Y.; Siebert, M.; Halimeh, S.: Development of an Adherence Questionnaire for Haemophilia Patients of the German Health System
P03-8
Escuriola-Ettingshausen, C.; Korsholm, L.; Matytsina, I.; Schutgens, R.: Safety and Efficacy of Turoctocog Alfa in Severe and Moderately Severe Previously Treated Patients with Haemophilia A: Interim Results after >4,000 Exposure Days (Guardian 5)
P03-9
von Depka, M. Prondzinski; Nawroth, B.; Wermes, C.; Henkel-Klene, A.; Detering, C.: Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding